A major international study published in The Lancet Public Health has found that India is over-relying on powerful "Watch" category antibiotics, while under-using first-line "Access" antibiotics — a pattern experts say points to both overuse and misuse of critical drugs, and raises concerns about antimicrobial resistance.
